CF
PRAX icon

CNA Financial’s Praxis Precision Medicines PRAX Stock Holding History

CNA Financial’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,249
Closed -$191K – 188
2022
Q1 		$191K Buy
1,249
+34
+3% +$6.98K 0.06% 181
2021
Q4 		$359K Buy
1,215
+92
+8% +$27K 0.09% 178
2021
Q3 		$311K Buy
1,123
+134
+14% +$36.4K 0.08% 185
2021
Q2 		$271K Buy
989
+327
+49% +$117K 0.08% 190
2021
Q1 		$325K Buy
662
+129
+24% +$91.7K 0.1% 186
2020
Q4 		$440K Buy
+533
New +$311K 0.14% 170

Other funds holding PRAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

CNA Financial's PRAX Position: Q2 2022 in Review

CNA Financial sold out of Praxis Precision Medicines (PRAX) in Q2 2022, closing a stake of 1,249 shares — an estimated $191K sold.

CNA Financial first reported a position in PRAX in Q4 2020 and held it in 6 quarters. The position peaked at $440K in Q4 2020. 95 funds tracked by Wall St. Rank hold PRAX as of Q2 2022.

  • CNA Financial reported no remaining Praxis Precision Medicines position as of Q2 2022 after selling out during the quarter.
  • CNA Financial sold 1,249 Praxis Precision Medicines shares in Q2 2022, an estimated $191K.
  • CNA Financial first reported a position in Praxis Precision Medicines in Q4 2020 and held it in 6 quarters.
  • CNA Financial's Praxis Precision Medicines position peaked at $440K in Q4 2020.
  • 95 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2022.

Based on CNA Financial's 13F filing for Q2 2022, filed 9 Aug 2022.